Effects of enamel matrix derivative and transforming growth factor-beta1 on human periodontal ligament fibroblasts.
OBJECTIVE
The objective of this study was to evaluate the effects of enamel matrix derivative (EMD), transforming growth factor-beta1 (TGF-beta1), and a combination of both factors (EMD+TGF-beta1) on periodontal ligament (PDL) fibroblasts.


METHODS
Human PDL fibroblasts were obtained from three adult patients with a clinically healthy periodontium, using the explant technique. The effects of EMD, TGF-beta1, or a combination of both were analysed on PDL cell proliferation, adhesion, wound healing, and total protein synthesis, and on alkaline phosphatase (ALP) activity and bone-like nodule formation.


RESULTS
Treatment with EMD for 4, 7, and 10 days increased cell proliferation significantly compared with the negative control (p<0.05). At day 10, EMD and EMD+TGF-beta1 showed a higher cell proliferation compared with TGF-beta1 (p<0.01). Cell adhesion was significantly up-regulated by TGF-beta1 compared with EMD and EMD+TGF-beta1 (p<0.01). EMD enhanced in vitro wound healing of PDL cells compared with the other treatments. Total protein synthesis was significantly increased in PDL cells cultured with EMD compared with PDL cells treated with TGF-beta1 or EMD+TGF-beta1 (p<0.05). EMD induced ALP activity in PDL fibroblasts, which was associated with an increase of bone-like nodules.


CONCLUSIONS
These findings support the hypothesis that EMD and TGF-beta1 may play an important role in periodontal regeneration. EMD induced PDL fibroblast proliferation and migration, total protein synthesis, ALP activity, and mineralization, while TGF-beta1 increased cellular adhesion. However, the combination of both factors did not positively alter PDL fibroblast behaviour.
Rodrigues
Thaisângela L S
TL
Department of Bucco-Maxillo-Facial Surgery and Traumatology and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Marchesan
Julie T
JT
Coletta
Ricardo D
RD
Novaes
Arthur B
AB
Grisi
Márcio F de M
MF
Souza
Sérgio L S
SL
Taba
Mário
M
Palioto
Daniela B
DB
D000328:Adult; D000469:Alkaline Phosphatase / Q000187:drug effects; D000963:Antimetabolites; D001672:Biocompatible Materials / Q000008:administration & dosage / Q000494:pharmacology*; D001973:Bromodeoxyuridine; D002113:Calcification, Physiologic / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D003746:Dental Enamel Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D004338:Drug Combinations; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D010513:Periodontal Ligament / Q000166:cytology / Q000187:drug effects*; D011506:Proteins / Q000187:drug effects; D013997:Time Factors; D053773:Transforming Growth Factor beta1 / Q000008:administration & dosage / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects; D014945:Wound Healing / Q000187:drug effects
D000963:Antimetabolites; D001672:Biocompatible Materials; D003746:Dental Enamel Proteins; D004338:Drug Combinations; D011506:Proteins; D053773:Transforming Growth Factor beta1; C109069:enamel matrix proteins; D000469:Alkaline Phosphatase; D001973:Bromodeoxyuridine